Home/Filings/4/0001209191-17-035514
4//SEC Filing

HCA Healthcare, Inc. 4

Accession 0001209191-17-035514

$HCACIK 0000860730operating

Filed

May 24, 8:00 PM ET

Accepted

May 25, 5:29 PM ET

Size

31.5 KB

Accession

0001209191-17-035514

Insider Transaction Report

Form 4
Period: 2017-05-23
Davis Jana Joustra
SVP - Communications
Transactions
  • Exercise/Conversion

    Common Stock

    2017-05-23$68.96/sh+5,500$379,280138,767 total
  • Tax Payment

    Common Stock

    2017-05-23$81.93/sh59,902$4,907,77181,427 total
  • Exercise/Conversion

    Stock Appreciation Right

    2017-05-2325,0000 total
    Exercise: $37.18Exp: 2023-02-06Common Stock (25,000 underlying)
  • Exercise/Conversion

    Stock Appreciation Right

    2017-05-2323,7500 total
    Exercise: $37.18Exp: 2023-02-06Common Stock (23,750 underlying)
  • Exercise/Conversion

    Stock Appreciation Right

    2017-05-2313,1254,375 total
    Exercise: $47.97Exp: 2024-02-05Common Stock (13,125 underlying)
  • Exercise/Conversion

    Stock Appreciation Right

    2017-05-2312,2500 total
    Exercise: $47.97Exp: 2024-02-05Common Stock (12,250 underlying)
  • Exercise/Conversion

    Stock Appreciation Right

    2017-05-235,5005,500 total
    Exercise: $68.96Exp: 2025-02-04Common Stock (5,500 underlying)
  • Exercise/Conversion

    Stock Appreciation Right

    2017-05-232,5627,688 total
    Exercise: $69.58Exp: 2026-01-29Common Stock (2,562 underlying)
  • Exercise/Conversion

    Common Stock

    2017-05-23$47.97/sh+25,375$1,217,239133,267 total
  • Exercise/Conversion

    Common Stock

    2017-05-23$69.58/sh+2,562$178,264141,329 total
  • Sale

    Common Stock

    2017-05-23$82.35/sh54,689$4,503,67726,378 total
  • Exercise/Conversion

    Common Stock

    2017-05-23$37.18/sh+48,750$1,812,525107,892 total
Holdings
  • Common Stock

    (indirect: By Trust)
    29,397
Footnotes (7)
  • [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $82.00 to $82.48, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F2]The stock appreciation rights vested in four equal annual installments beginning on February 6, 2014.
  • [F3]The stock appreciation rights vested at the end of fiscal years 2013, 2014, 2015 and 2016 based upon the achievement of certain annual EBITDA performance targets.
  • [F4]The stock appreciation rights vest in four equal annual installments beginning on February 5, 2015.
  • [F5]The stock appreciation rights vested at the end of fiscal years 2014, 2015 and 2016 based upon the achievement of certain annual EBITDA performance targets.
  • [F6]The stock appreciation rights vest in four equal annual installments beginning on February 4, 2016.
  • [F7]The stock appreciation rights vest in four equal annual installments beginning on January 29, 2017.

Issuer

HCA Healthcare, Inc.

CIK 0000860730

Entity typeoperating

Related Parties

1
  • filerCIK 0000860730

Filing Metadata

Form type
4
Filed
May 24, 8:00 PM ET
Accepted
May 25, 5:29 PM ET
Size
31.5 KB